Esophagitis and Pneumonitis Related to Concurrent Chemoradiation ± Durvalumab Consolidation in Unresectable Stage III Non-Small-Cell Lung Cancer: Risk Assessment and Management Recommendations Based on a Modified Delphi Process.
- DOI
- 10.3390/curroncol31110483
- Published
- 2024 Oct 23
- Container
- Current oncology (Toronto, Ont.)
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.3390/curroncol31110483,
title = {Esophagitis and Pneumonitis Related to Concurrent Chemoradiation ± Durvalumab Consolidation in Unresectable Stage III Non-Small-Cell Lung Cancer: Risk Assessment and Management Recommendations Based on a Modified Delphi Process.},
author = {Brade AM and Bahig H and Bezjak A and Juergens RA and Lynden C and Marcoux N and Melosky B and Schellenberg D and Snow S},
year = {2024},
journal = {Current oncology (Toronto, Ont.)},
doi = {10.3390/curroncol31110483},
url = {https://doi.org/10.3390/curroncol31110483}
}RIS
TY - JOUR TI - Esophagitis and Pneumonitis Related to Concurrent Chemoradiation ± Durvalumab Consolidation in Unresectable Stage III Non-Small-Cell Lung Cancer: Risk Assessment and Management Recommendations Based on a Modified Delphi Process. AU - Brade AM AU - Bahig H AU - Bezjak A AU - Juergens RA AU - Lynden C AU - Marcoux N AU - Melosky B AU - Schellenberg D AU - Snow S PY - 2024 JO - Current oncology (Toronto, Ont.) DO - 10.3390/curroncol31110483 UR - https://doi.org/10.3390/curroncol31110483 ER -
APA
AM, B., H, B., A, B., RA, J., C, L., N, M., B, M., D, S., & S, S. (2024). Esophagitis and Pneumonitis Related to Concurrent Chemoradiation ± Durvalumab Consolidation in Unresectable Stage III Non-Small-Cell Lung Cancer: Risk Assessment and Management Recommendations Based on a Modified Delphi Process.. Current oncology (Toronto, Ont.). https://doi.org/10.3390/curroncol31110483
Source records
- pubmed · retrieved 2026-09-26T23:03:25.552Z